Pharmacokinetics of intrapericardial administration of 5-fluorouracil

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 4, 1997, Pages 318-320

  Lerner Tung, Mary B ^a   Chang, Alex Y C ^a,b   Ong, Ling S ^a   Kreiser, Deborah ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b Interlakes Oncology and Hematology PC   (United States)

Author keywords

5 Fluorouracil; Breast cancer; Malignant pericardial effusion; Pharmacokinetics

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; MORPHINE SULFATE; TOBRAMYCIN; VANCOMYCIN;

AREA UNDER THE CURVE; ARTICLE; BREAST ADENOCARCINOMA; CASE REPORT; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INFUSION; DRUG MONITORING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; METASTASIS; PERICARDIAL EFFUSION; PERICARDIUM; PRIORITY JOURNAL; URINARY TRACT INFECTION;

ADENOCARCINOMA; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BREAST NEOPLASMS; CISPLATIN; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; PERICARDIAL EFFUSION; PERICARDIUM;

EID: 0030991884     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050663     Document Type: Article

References (14)

1. Bindi M, Trusso M, Tucci E (1987) Intracavitary cisplatin in malignant cardiac tamponade. Tumori 73: 163
2. Buck M, Ingle JN, Giuliani ER, Gordon JR, Therneau TM (1987) Pericardial effusion in women with breast cancer. Cancer 60: 263
3. Chabner BA (1982) Pyrimidine antagonists. In: Chabner BA (ed) Pharmacologic principles of cancer treatment. W.B. Saunders, Philadelphia, p 183
4. Koester WM, Winkelmann M (1994) Intrapericardial cisplatin therapy of malignant pericardial effusions. (letter). Eur J Cancer 30A: 131
5. Nelson BE, Rose PG (1993) Malignant pericardial effusion from squamous cell cancer of the cervix. J Surg Oncol 52: 203
6. Pogolotti AL, Nolan PA, Santi DV (1981) Methods for the complete analysis of 5-fluorouracil metabolites in cell extracts. Anal Biochem 117: 178
7. Reynolds PM, Byrne MJ (1977) The treatment of malignant pericardial effusion in carcinoma of the breast. Aust NZ J Med 7: 169
8. Rowland M, Tozer TN (1989) Clinical pharmacokinetics: concepts and applications. Lea & Febiger, Philadelphia, p 459
9. Smith FE, Lane M, Hudgins PT (1974) Conservative management of malignant pericardial effusion. Cancer 33: 47
10. Strang JIG (1994) Rapid resolution of tuberculous pericardial effusions with high dose prednisone and anti-tuberculous drugs. J Infect 28: 251
11. Suhrland LG, Weisberger AS (1965) Intracavitary 5-fluorouracil in malignant effusions. Arch Intern Med 116: 431
12. Tomkowski W, Szturmowicz M, Fijalkowska A, Filipecki S, Figura-Chojak E (1994) Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. J Clin Res Clin Oncol 120: 434
13. Vaitkus PT, Hermann HC, LeWinter MM (1994) Treatment of malignant pericardial effusion. JAMA 272: 59
14. Woll PJ, Knight RK, Rubens RD (1987) Pericardial effusion complicating breast cancer. JR Soc Med 80: 490